From October 1, 2021 to December 31, 2021, the company has repurchased 4,307,000 shares, representing 0.79% for CNY 70 million. With this, the company has completed the repurchase of 6,877,000 shares, representing 1.26% for CNY 105.09 million under the buyback announced on August 4, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.63 CNY | +2.56% | -3.70% | +2.88% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.88% | 698M | |
+47.53% | 779B | |
+40.67% | 631B | |
-6.60% | 354B | |
+20.55% | 333B | |
+8.32% | 301B | |
+16.75% | 249B | |
-1.19% | 216B | |
+10.85% | 214B | |
+4.30% | 163B |
- Stock Market
- Equities
- 300497 Stock
- News Jiangxi Fushine Pharmaceutical Co., Ltd.
- Tranche Update on Jiangxi Fushine Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on August 4, 2021.